Methods of treating prostate cancer
The present application relates to treating and/or preventing prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer,...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
12.05.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present application relates to treating and/or preventing prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in a subject in need of treatment, comprising administering a compound of Formula (I), (I), or a pharmaceutically acceptable salt, enantiomer, stereoisomer, solvate, polymorph, isotopic derivative, or prodrug thereof, wherein R |
---|---|
Bibliography: | Application Number: AU20200370150 |